Bertin Ushizimpumu

Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in Rwanda.

L. Rigouts, W. B. de Rijk, B. D. de Jong, 2020, The Lancet. Microbe.

Case Report: Dynamics of Acquired Fluoroquinolone Resistance under Standardized Short-Course Treatment of Multidrug-Resistant Tuberculosis

L. Rigouts, B. D. de Jong, A. Van Deun, 2020, The American journal of tropical medicine and hygiene.

Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter century

L. Rigouts, Cécile Uwizeye, B. D. de Jong, 2022, Journal of clinical tuberculosis and other mycobacterial diseases.